{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T02:09:22Z","timestamp":1743127762582,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781441971845"},{"type":"electronic","value":"9781441971852"}],"license":[{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4419-7185-2_12","type":"book-chapter","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T18:33:54Z","timestamp":1291142034000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxic Shock Syndrome \u2013 Evolution of an Emerging Disease"],"prefix":"10.1007","author":[{"given":"James K.","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"issue":"8100","key":"12_CR1","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(78)92274-2","volume":"2","author":"J Todd","year":"1978","unstructured":"Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978;2(8100):1116\u20138.","journal-title":"Lancet"},{"issue":"4","key":"12_CR2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/infdis\/155.4.673","volume":"155","author":"JK Todd","year":"1987","unstructured":"Todd JK, Todd BH, Franco-Buff A, Smith CM, Lawellin DW. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J Infect Dis. 1987;155(4):673\u201381.","journal-title":"J Infect Dis"},{"issue":"25","key":"12_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJM198012183032502","volume":"303","author":"KN Shands","year":"1980","unstructured":"Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303(25):1436\u201342.","journal-title":"N Engl J Med"},{"issue":"5","key":"12_CR4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/oxfordjournals.aje.a114168","volume":"122","author":"JK Todd","year":"1985","unstructured":"Todd JK, Wiesenthal AM, Ressman M, Caston SA, Hopkins RS. Toxic shock syndrome. II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am J Epidemiol. 1985;122(5):857\u201367.","journal-title":"Am J Epidemiol"},{"unstructured":"Todd J, Kurtz B, Combs P, Todd A, Anderson J Epidemiology of toxic shock syndrome 1970\u20131996. Royal Society of Medicine Congress Symposium Series; 1998. p. 229.","key":"12_CR5"},{"issue":"3","key":"12_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.255.3.368","volume":"255","author":"DB Petitti","year":"1986","unstructured":"Petitti DB, Reingold A, Chin J. The incidence of toxic shock syndrome in Northern California: 1972 through 1983. JAMA. 1986;255(3):368\u201372.","journal-title":"JAMA"},{"issue":"3","key":"12_CR7","first-page":"19SS","volume":"33","author":"AL Reingold","year":"1984","unstructured":"Reingold AL. Epidemiology of toxic-shock syndrome, United States, 1960\u20131984. MMWR CDC Surveill Summ. 1984;33(3):19SS\u201322SS.","journal-title":"MMWR CDC Surveill Summ"},{"issue":"1","key":"12_CR8","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/clinids\/11.Supplement_1.S14","volume":"11","author":"CV Broome","year":"1989","unstructured":"Broome CV. Epidemiology of toxic shock syndrome in the United States: overview. Rev Infect Dis. 1989;11(Suppl 1):S14\u201321.","journal-title":"Rev Infect Dis"},{"issue":"19","key":"12_CR9","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1001\/jama.246.19.2163","volume":"246","author":"RW Tofte","year":"1981","unstructured":"Tofte RW, Williams DN. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA. 1981;246(19):2163\u20137.","journal-title":"JAMA"},{"issue":"1","key":"12_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1542\/peds.74.1.112","volume":"74","author":"AM Wiesenthal","year":"1984","unstructured":"Wiesenthal AM, Todd JK. Toxic shock syndrome in children aged 10 years or less. Pediatrics. 1984;74(1):112\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"12_CR11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/iai.46.2.590-597.1984","volume":"46","author":"MW Reeves","year":"1984","unstructured":"Reeves MW, Pine L, Feeley JC, Wells DE. Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus. Infect Immun. 1984;46(2):590\u20137.","journal-title":"Infect Immun"},{"issue":"1","key":"12_CR12","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/clinids\/11.Supplement_1.S75","volume":"11","author":"GA Bohach","year":"1989","unstructured":"Bohach GA, Kreiswirth BN, Novick RP, Schlievert PM. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays. Rev Infect Dis. 1989;11(Suppl 1):S75\u201381. Discussion S\u20132.","journal-title":"Rev Infect Dis"},{"issue":"3","key":"12_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.172.3.981","volume":"172","author":"Y Choi","year":"1990","unstructured":"Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med. 1990;172(3):981\u20134.","journal-title":"J Exp Med"},{"issue":"4","key":"12_CR14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/148.4.692","volume":"148","author":"JM Vergeront","year":"1983","unstructured":"Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis. 1983;148(4):692\u20138.","journal-title":"J Infect Dis"},{"issue":"3","key":"12_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10875-007-9072-4","volume":"27","author":"R Kansal","year":"2007","unstructured":"Kansal R, Davis C, Hansmann M, Seymour J, Parsonnet J, Modern P, et al. Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome. J Clin Immunol. 2007;27(3):327\u201338.","journal-title":"J Clin Immunol"},{"issue":"1","key":"12_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/JCM.01626-07","volume":"46","author":"B Luca-Harari","year":"2008","unstructured":"Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol. 2008;46(1):79\u201386.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"12_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1086\/516129","volume":"25","author":"G Lina","year":"1997","unstructured":"Lina G, Gillet Y, Vandenesch F, Jones ME, Floret D, Etienne J. Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis. 1997;25(6):1369\u201373.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1001\/archoto.2009.55","volume":"135","author":"KH Chan","year":"2009","unstructured":"Chan KH, Kraai TL, Richter GT, Wetherall S, Todd JK. Toxic shock syndrome and rhinosinusitis in children. Arch Otolaryngol Head Neck Surg. 2009;135(6):538\u201342.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"12_CR19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/infdis\/161.5.953","volume":"161","author":"MA Ferguson","year":"1990","unstructured":"Ferguson MA, Todd JK. Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children. J Infect Dis. 1990;161(5):953\u20135.","journal-title":"J Infect Dis"},{"issue":"3","key":"12_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jinf.2009.06.010","volume":"59","author":"N Takahashi","year":"2009","unstructured":"Takahashi N, Uehara R, Nishida H, Sakuma I, Yamasaki C, Takahashi K, et al. Clinical features of neonatal toxic shock syndrome-like exanthematous disease emerging in Japan. J Infect. 2009;59(3):194\u2013200.","journal-title":"J Infect"},{"issue":"25","key":"12_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJM198012183032501","volume":"303","author":"JP Davis","year":"1980","unstructured":"Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980;303(25):1429\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"12_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","volume":"158","author":"DL Stevens","year":"1988","unstructured":"Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158(1):23\u20138.","journal-title":"J Infect Dis"},{"issue":"12","key":"12_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","volume":"18","author":"J Zimbelman","year":"1999","unstructured":"Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18(12):1096\u2013100.","journal-title":"Pediatr Infect Dis J"},{"issue":"24","key":"12_CR24","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1001\/jama.252.24.3399","volume":"252","author":"JK Todd","year":"1984","unstructured":"Todd JK, Ressman M, Caston SA, Todd BH, Wiesenthal AM. Corticosteroid therapy for patients with toxic shock syndrome. JAMA. 1984;252(24):3399\u2013402.","journal-title":"JAMA"},{"issue":"6","key":"12_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2165\/00003495-199039060-00004","volume":"39","author":"JK Todd","year":"1990","unstructured":"Todd JK. Therapy of toxic shock syndrome. Drugs. 1990;39(6):856\u201361.","journal-title":"Drugs"},{"issue":"9","key":"12_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/00365540310015944","volume":"35","author":"A Norrby-Teglund","year":"2003","unstructured":"Norrby-Teglund A, Ihendyane N, Darenberg J. Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections. Scand J Infect Dis. 2003;35(9):683\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"12_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10096-007-0405-2","volume":"27","author":"E Descloux","year":"2008","unstructured":"Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, et al. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis. 2008;27(1):37\u201343.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1 Pt 1","key":"12_CR28","first-page":"136","volume":"101","author":"American Academy of Pediatrics","year":"1998","unstructured":"American Academy of Pediatrics. Committee on infectious diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics. 1998;101(1 Pt 1):136\u201340.","journal-title":"Pediatrics"},{"issue":"24","key":"12_CR29","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1001\/jama.252.24.3402","volume":"252","author":"SD Helgerson","year":"1984","unstructured":"Helgerson SD, Mallery BL, Foster LR. Toxic shock syndrome in Oregon. Risk of recurrence. JAMA. 1984;252(24):3402\u20134.","journal-title":"JAMA"}],"container-title":["Advances in Experimental Medicine and Biology","Hot Topics in Infection and Immunity in Children VII"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-7185-2_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:34:29Z","timestamp":1675902869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4419-7185-2_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"ISBN":["9781441971845","9781441971852"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-7185-2_12","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[2010,9,3]]},"assertion":[{"value":"3 September 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}